+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Burden of Hepatitis C in Iran Between 1990 and 2010: findings from the Global Burden of Disease Study 2010



Burden of Hepatitis C in Iran Between 1990 and 2010: findings from the Global Burden of Disease Study 2010



Archives of Iranian Medicine 18(8): 508-514



Hepatitis C virus (HCV) is the foremost cause of deaths attributable to cirrhosis and hepatocellular carcinoma. The Global Burden of Disease study 2010 (GBD 2010) quantifies and compares the degree of health loss as a result of diseases, injuries, and risk factors by age, sex, and geography overtime. This study aimed to present and critique the burden of hepatitis C and its trend in Iran between 1990 and 2010 by using the GBD study 2010. We used the results of GBD 2010 for Iran to measure rates and trends of mortality, causes of deaths, years of life lost (YLLs), years lived with disability (YLDs), and disability adjusted life years (DALYs) due to hepatitis C. Hepatitis C was defined as the presence of hepatitis C virus in the serum. Data were presented in three categories: acute hepatitis C, cirrhosis secondary to hepatitis C, and liver cancer secondary to hepatitis C. HCV infection (including the three categories of the study) led to 57.29, 59.92, and 66.45 DALYs (per 100,000 population) in 1990, 2000, and 2010, respectively. DALYs and death rates showed a slight decreasing trend for HCV cirrhosis; however, DALYs and death rates increased for acute hepatitis and liver cancer due to patients with HCV. The majority of deaths and DALYs were in individuals aged 70 years and above in all three categories of HCV. YLLs made the greatest contributions to DALYs. DALYs due to HCV infection are increasing in Iran according to GBD 2010; however, the estimations of DALYs using GBD 2010 are mostly from model-based data and there are significant uncertainties for extrapolated data. In this regard, a comprehensive study such as the National and Subnational Burden of Diseases (NASBOD) study would be needed to estimate and calculate precisely prevalence and burden of HCV-related diseases at national and subnational levels.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 057331470

Download citation: RISBibTeXText

PMID: 26265519


Related references

A Burden Assessment of Occupational Exposures in Iran, 1990-2010: Findings from the Global Burden of Disease Study 2010. International Journal of Preventive Medicine 9: 56, 2018

Burden of ischemic heart diseases in Iran, 1990-2010: Findings from the Global Burden of Disease study 2010. Journal of Research in Medical Sciences 20(11): 1077-1083, 2016

Burden of Oral Diseases in Iran, 1990-2010: Findings from the Global Burden of Disease Study 2010. Archives of Iranian Medicine 18(8): 486-492, 2016

Tobacco Smoking Status and the Contribution to Burden of Diseases in Iran, 1990-2010: findings from the Global Burden of Disease Study 2010. Archives of Iranian Medicine 18(8): 493-501, 2016

Burden of Malaria in Iran, 1990-2010: Findings from the Global Burden of Disease Study 2010. Archives of Iranian Medicine 19(4): 241-247, 2017

Burden of Cancers in Iran from 1990 to 2010: findings from the Global Burden of Disease study 2010. Archives of Iranian Medicine 18(10): 629-637, 2016

Trends in health burden of untreated water and insanitary environments in Iran, 1990-2010: Findings from the global burden of disease study 2010. Medical Journal of the Islamic Republic of Iran 30: 424, 2017

Trends in health burden of ambient particulate matter pollution in Iran, 1990-2010: findings from the Global Burden of Disease study 2010. Environmental Science and Pollution Research International 22(23): 18645-18653, 2016

Burden of Hemoglobinopathies (Thalassemia, Sickle Cell Disorders and G6PD Deficiency) in Iran, 1990-2010: findings from the Global Burden of Disease Study 2010. Archives of Iranian Medicine 18(8): 502-507, 2016

Burden of Sexually Transmitted Infections in Iran from 1990 to 2010: Results from the Global Burden of Disease study 2010. Archives of Iranian Medicine 19(11): 768-773, 2017

Burden Assessment of Thyroid cancer in Iran from 1990 to 2010: Lessons Obtained from Global Burden of Disease Report 2010. Asian Pacific Journal of Cancer Prevention 16(17): 7743-7748, 2016

Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet. Global Health 1(5): E259-E281, 2015

Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 383(9913): 245-254, 2014

National Burden of Eye Diseases in Iran, 1990-2010; Findings from the Global Burden of Diseases Study 2010. Middle East African Journal of Ophthalmology 23(1): 89-95, 2016

Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 381(9882): 1987-2015, 2013